Controversy has broken out in India regarding access to two treatments that are used to address drug resistant tuberculosis (TB). The medications, bedaquiline and delamanid are all but unavailable in India, with fewer than 1,000 DR-TB patients in India receiving bedaquiline and only 81 receive delamanid. This has led to calls for the issuing of … [Read more...] about TB ‘miracle cures’ and the issue of high expectations
Archives for March 2018
India holds a unique position in the generic market. Commonly referred to as the “pharmacy of the developing world”, India exports huge volumes of generic medication. This forms a multi-billion dollar industry within India. This low cost generics market has improved access to lower price medications in India, as well as allowed for the export … [Read more...] about Indian patent laws, no longer the pharmacy of the developing world?
A hard Brexit could be good news for the tobacco industry, warns an anti-smoking charity in Scotland. The warning comes amidst fears the UK government and tobacco companies - particularly British American Tobacco (BAT) - are becoming a little too close for comfort. Vulnerable to tobacco lobbying ASH Scotland has told a committee they are … [Read more...] about Brexit: A boon for Big Tobacco?
Early-stage human trials have shown that a potential treatment for Huntington’s disease -- devised by University College London -- is both safe and potentially effective. But is it a “breakthrough that may stop the disease” that media reports claim? Huntington's disease, as of yet, has no cure. IONIS-HTTRx, a potential cure? The potential new … [Read more...] about New hope for Huntington’s disease?